Literature DB >> 29470262

Serum S100 Proteins as a Marker of Disease Activity in Large Vessel Vasculitis.

Jason Michael Springer1, Paul Monach, David Cuthbertson, Simon Carette, Nader A Khalidi, Carol A McAlear, Christian Pagnoux, Philip Seo, Kenneth J Warrington, Steven R Ytterberg, Gary Hoffman, Carol Langford, Thomas Hamilton, Dirk Foell, Thomas Vogl, Dirk Holzinger, Peter A Merkel, Johannes Roth, Rula A Hajj-Ali.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29470262      PMCID： PMC6105726          DOI： 10.1097/RHU.0000000000000729

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  14 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

2.  Phagocyte-specific S100A8/A9 protein levels during disease exacerbations and infections in systemic lupus erythematosus.

Authors:  Muhammad S Soyfoo; Johannes Roth; Thomas Vogl; Roland Pochet; Guy Decaux
Journal:  J Rheumatol       Date:  2009-09-15       Impact factor: 4.666

3.  The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.

Authors:  W P Arend; B A Michel; D A Bloch; G G Hunder; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

4.  Morphological changes in the large arteries in polymyalgia arteritica.

Authors:  G Ostberg
Journal:  Acta Med Scand Suppl       Date:  1972

5.  The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function.

Authors:  N Lügering; R Stoll; K W Schmid; T Kucharzik; H Stein; G Burmeister; C Sorg; W Domschke
Journal:  Eur J Clin Invest       Date:  1995-09       Impact factor: 4.686

6.  Pentraxin-3 as a marker of disease activity in Takayasu arteritis.

Authors:  Lorenzo Dagna; Fulvio Salvo; Mirta Tiraboschi; Enrica P Bozzolo; Stefano Franchini; Claudio Doglioni; Angelo A Manfredi; Elena Baldissera; Maria Grazia Sabbadini
Journal:  Ann Intern Med       Date:  2011-10-04       Impact factor: 25.391

7.  Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.

Authors:  D Foell; D Kane; B Bresnihan; T Vogl; W Nacken; C Sorg; O Fitzgerald; J Roth
Journal:  Rheumatology (Oxford)       Date:  2003-06-27       Impact factor: 7.580

8.  Early recruitment of phagocytes contributes to the vascular inflammation of giant cell arteritis.

Authors:  Dirk Foell; José Hernández-Rodríguez; Montse Sánchez; Thomas Vogl; Maria C Cid; Johannes Roth
Journal:  J Pathol       Date:  2004-11       Impact factor: 7.996

9.  Takayasu arteritis.

Authors:  G S Kerr; C W Hallahan; J Giordano; R Y Leavitt; A S Fauci; M Rottem; G S Hoffman
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

10.  Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis--a prospective longitudinal study.

Authors:  Sudha Visvanathan; Mahboob U Rahman; Gary S Hoffman; Stephen Xu; Ana García-Martínez; Marta Segarra; Ester Lozano; Georgina Espígol-Frigolé; José Hernández-Rodríguez; Maria C Cid
Journal:  Rheumatology (Oxford)       Date:  2011-08-25       Impact factor: 7.580
View more
  1 in total

Review 1.  Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.

Authors:  Dario Camellino; Eric L Matteson; Frank Buttgereit; Christian Dejaco
Journal:  Nat Rev Rheumatol       Date:  2020-08-05       Impact factor: 20.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.